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Biphasic contrast medium injection in cardiac
CT: moderate versus high concentration
contrast material at identical iodine flux
and iodine dose
Abstract Objective: To prospec-
tively investigate the influence of
contrast material concentration on
enhancement in cardiac CT by using a
biphasic single-injection protocol.
Methods: Sixty-four-row multidetec-
tor cardiac CT angiography was
performed in 159 patients randomised
to a moderate or high contrast medi-
um concentration. Contrast material
injection included a first phase for
enhancement of the coronary arteries
and a second phase, at half the iodine
flux, targeted at enhancement of the
right ventricle. Contrast medium
injection was followed by a saline
flush. For both concentrations,
injection duration (and thus total
iodine dose) was adapted to the
duration of the CT data acquisition
and iodine flux was adjusted to
patient weight. Attenuation was
measured at various levels in the heart
and vessels and the two concentra-
tions compared, overall and per
weight group. Results: Enhancement
of the aorta and left ventricle was
significantly greater with the
moderate than with the high concen-
tration contrast medium. This
remained true for the two higher
weight groups. No difference was
found in the lowest weight group or in
the right ventricle and pulmonary
outflow tract. Conclusion: With a
biphasic injection protocol, enhance-
ment of the aorta and left ventricle was
weakerwiththehigherconcentrationof
contrast material.
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Introduction
Thenewgenerationsofmultidetectorcomputedtomography
(CT) (≥64-detector row) have substantially decreased the
duration of CT data acquisition for cardiac CT angiography
(CTA). These new systems even allow ECG-synchronised
CTofthecompletethoraxforatriplerule-outprotocolwithin
a single breath-hold [1]. Adjustments to contrast medium
injection protocols are required to obtain a high level of
arterial enhancement faster and to combine left ventricular/
coronary artery enhancement with right ventricular/pulmo-
nary artery enhancement. Recently biphasic injection
protocols have been described that achieve this combination
[1, 2].
Arterial enhancement is determined by patient-related
factors (e.g. blood volume, cardiac output) and the contrast
medium injection parameters (e.g. contrast material con-
centration, contrast material volume, flow rate, added
saline chaser bolus) [3–5]. Iodine flux (flow rate × iodine
concentration) and iodine dose (contrast material volume ×
iodine concentration) are considered to be the determining
factors for enhancement [4, 6]. There are publications that
suggest that a higher iodine concentration provides supe-
rior enhancement characteristics, but theoretically this
superior enhancement can also be achieved by an increase
in contrast medium injection rate (iodine flux in grams of
iodine injected per second = injection rate × concentration)
[3, 4, 6–9].
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Berlin, GermanyWe evaluated the effect of contrast medium concentra-
tion on cardiac and arterial enhancement in 64-row
multidetector cardiac CT by using a biphasic injection
protocol for differential enhancement of the coronary
arteries and the right ventricle. High initial contrast
injection rates with adjustments for patient weight
and duration of CT data acquisition were applied to
obtain optimal enhancement of the coronary arteries for
assessment of coronary artery disease and of both the left
and the right ventricle for functional analyses. While two
different contrast medium concentrations were used, iodine
flux and iodine dose were kept constant by adapting
contrast medium volume and injection rate. Our hypothesis
was that no substantial differences in enhancement
between the two contrast medium concentrations would
be detected.
Materials and methods
The institutional review board granted permission to
perform this study. All patients signed informed consent.
We included 182 consecutive patients scheduled for
cardiac CT. They received contrast medium with either
300 mg iodine (I)/ml or 370 mg I/ml (Iopromide, Schering,
Berlin, Germany) during the examination. Sixty-four-row
multidetector cardiac CT was performed (Brilliance 64,
Philips Medical Systems, Cleveland, OH, USA). CT
parameters are summarised in Table 1.
Exclusion criteria Patients were excluded if a needle
smaller than 18 gauge (G) was used for intravenous
injection because of the small vessel size, as an 18-G
needle was needed to accommodate the applied flow rates,
or if the imaging range was extended beyond the region of
the heart. Twenty-three of the 182 consecutive patients
undergoing cardiac CTwere excluded. A 20-G needle was
used in 6 patients because of the small vessel size, 8
patients had to undergo a cardiac CT with an extended
imaging range, e.g. bypass graft evaluation, and 9 patients
were excluded because of deviations from the CT
protocol, such as change of post-threshold delay, which
could influence contrast enhancement.
Contrast medium injection protocol
Randomisation to one of the two contrast medium
concentrations was performed on a per day basis for
logistic reasons, e.g. changing contrast material takes
valuable time, and wastage of contrast medium remaining
in the injector after the previous contrast-enhanced CT
examination. We applied a biphasic contrast injection
protocol modified from Garcia et al. [10] with two
connected phases of contrast medium injection immedi-
ately followed by a saline flush of 30 ml injected with a
dual syringe injector (Stellant D, Medrad, Indiana, PA,
USA). This protocol was used to prevent washout of the
right ventricle to allow functional analyses of both
Table 1 Imaging parameters
Imaging parameter Value
Collimation (mm) 64×0.625
Direction ↓
Imaging range 15 mm above highest coronary artery to 15 mm below heart
ECG synchronisation Retrospective gating
Location bolus tracker ROI In descending aorta at start of planned imaging range
Bolus tracker threshold (HU) 100
Start delay 8 s after reaching threshold
Imaging length (cm) 10–16 (average 12)
Imaging duration (s) 8–11 (average 10)
Pitch 0.2
Peak tube potential (kVp) 120
Tube current (mAs) 500–1,000 (depending on patient size)
Dose modulation ECG-based at 70% to 80% phase if regular heart rate below 60 bpm
FOV (mm) 205
Matrix 512×512
Reconstruction filter Cardiac B (medium)
Reconstructed section thickness (mm) 0.9
Reconstructed section increment (mm) 0.45
Reconstructed phases Every 10% of RR interval
1918ventricles in addition to the coronary artery analysis. A
similar contrast medium injection protocol is suggested for
triple rule-out studies to achieve adequate enhancement of
the aorta, coronary arteries and the pulmonary artery [1].
The first contrast medium injection phase is similar to
the single contrast medium injection phase commonly used
for cardiac CTA and yields sufficient enhancement of the
coronary arteries [5, 11, 12]. The second, directly
consecutive, contrast medium injection phase was applied
to prevent washout of the right ventricle, a portion of the
circulation proximal to the coronary arteries, and thus to
allow analysis of left and right ventricular function,
including left ventricular wall thickness and thickening,
which is not possible with complete washout of the right
ventricle.
Each patient was assigned to one of three weight
categories, each with its own iodine flux (g/s) for the first
injection phase (<70 kg: 1.6 g/s; 70–85 kg: 1.8 g/s; >85 kg:
2.0 g/s) (Table 2). Iodine flux was independent of the
contrast medium concentration used. The duration of the
first injection phase was determined in a similar way to that
for single phase CTA, and was calculated from the duration
of CT data acquisition plus 8 s, the duration of the post-
threshold delay for bolus triggering.
Iodine flux in the second contrast medium phase was
50% of the flux in the first phase. Injection duration for the
second phase was fixed at 10 s. Between the two contrast
medium injection phases and between contrast medium
injection and saline flush no time delay occurred. The flow
rate (ml/s) during each phase of the contrast medium
injection and the volume of contrast medium (ml) to be
injected during each phase was calculated in a spreadsheet
program (Excel, Microsoft Office 2003, Redmond, WA)
(Table 2). Maximum flow rate was 6.7 ml/s with a contrast
medium concentration of 300 mg I/ml. The total iodine
dose (g) injected could be calculated by multiplying iodine
flux and injection duration and was also independent of
contrast medium concentration. The 370 mg I/ml contrast
material was preheated to 37°C before use to decrease the
viscosity. Bolus tracking with a region of interest (ROI) in
the descending aorta at the start of the imaging range was
used to time the CT data acquisition which started 8 s after
reaching the threshold value of 100 HU. Time to threshold
and the maximum injection rate reached were recorded.
Enhancement evaluation
Vascular enhancement was measured by placing ROIs of
1c m
2 in the left and right ventricle and the descending
aorta at three levels (cranial, mid and caudal) and in
the ascending aorta and pulmonary artery, right above
the aortic and pulmonary valve, respectively. Contrast
enhancement in these structures was considered represen-
tative of enhancement in the coronary arteries with the
advantages that large ROI sizes and standardised measure-
ment locations could be used. At each measurement site
ROIs were placed on three adjacent slices and attenuation
values were averaged before further analysis. Visible
artefacts were excluded from the measurements. Measure-
ments for the enhancement evaluation were performed
during a diastolic phase (reconstruction at 80% of RR
interval).
Contrast opacification in the coronary arteries was
subjectively scored on a 5-point scale (1=poor, 5=
excellent). Patients were interviewed after the examination
to determine patient (dis)comfort on a scale from 1 to
10 (1=severe discomfort, 10=no discomfort at all). Any
allergoid reactions and contrast extravasations were
recorded.
Table 2 Contrast medium injection protocol
Injection
phase
a
Weight
group (kg)
Iodine flux
I (g/s)
Flow rate F (ml/s) Volume V (ml)
b Injection duration T (s)
Contrast medium concentration Contrast medium concentration
300 mg/ml 370 mg/ml 300 mg/ml 370 mg/ml
I <70 1.6 5.3 4.3 85–101 69–82 Imaging duration + 8
c
70–85 1.8 6.0 4.9 96–114 78–93
>85 2.0 6.7 5.4 107–127 86–103
II <70 0.8 2.7 2.2 27 22 10
70–85 0.9 3.0 2.4 30 24
>85 1.0 3.3 2.7 33 27
The injected amount of iodine M (total iodine dose) per phase can be calculated from T and iodine flux I: M=T×I. Iodine flux I and total
iodine dose M are independent of contrast material concentration and are the same for both contrast material concentrations
aPhase II immediately followed phase I and a saline flush of 30 ml with the same flow rate as phase II was always performed immediately
after phase II
bVolume is given as range. For an individual patient exact contrast material volume in each phase can be calculated from injection duration T
and flow rate F as follows: V=T×F
cStart delay for bolus tracking was set to 8 s after reaching a threshold level of 100 HU in an ROI in the descending aorta at the start of the
planned imaging range (i.e. 15 mm above the highest coronary artery)
1919Statistical analysis
Continuous variables were summarised by using mean and
standard deviation, and categorical variables by using
median and range. An independent t test was used to
compare the two groups in the case of continuous measures
such as vascular enhancement for each measurement
location. In the case of categorical variables, such as
subjective scores for opacification, a Wilcoxon rank sum
test was used to compare the two groups. A p value less
than 0.05 was considered significant. Data analysis was
performed in SPSS for Windows (Version 12.0.1, 2004,
Chicago, IL, USA).
Results
Patient characteristics of the included patients are sum-
marised in Table 3. Patient comfort scores were a median of
7 in both groups (p>0.05). No contrast extravasations
occurred. Four patients developed a mild allergoid reaction
(nausea or urticaria), three patients in the high concentra-
tion group and one patient in the moderate concentration
group. Intended contrast medium injection rates were
always reached including the maximum injection rate of
6.7 ml/s. Mean time to threshold was 19 s (range 16–25 s)
for the 300 mg I/ml group and 20 s (range 15–25 s) for the
370 mg I/ml group (p>0.05).
Vascular enhancement
In the overall population mean attenuation in the aorta and
left ventricle was significantly higher (p<0.001) in the
subjects in the moderate concentration group (Fig. 1). This
significantly higher mean attenuation was also found in the
two higher weight groups (≥70 kg) (p<0.05). This
difference was not found in the lowest weight group
(<70 kg) (p>0.05). The mean attenuation at the various
levels in the right ventricle and in the pulmonary artery
were never shown to be significantly different (p>0.05).
Despite the use of a weight-adapted contrast medium
injection protocol with increasing iodine flux and iodine
dose for heavier patients the attenuation decreased with
increasing weight (Fig. 2). Figure 3 provides examples of
CT images from both groups.
Subjective scores
In both groups scores of 3 (i.e. adequate) or more were
given for the contrast opacification in the coronary arteries.
The subjective scores of the coronary arteries were
on average slightly, but not significantly, higher in the
lower contrast medium concentration group (4.1 vs. 3.7)
(p>0.05).
Discussion
In this study we found a difference in arterial enhancement
between high and moderate contrast medium concentra-
tions in favour of the moderate concentration. This was
seen despite injection protocols based on identical iodine
flux and iodine dose, which theoretically should yield no
difference in enhancement. Our finding seems to contradict
the conclusion of previous studies comparing different
contrast medium concentrations for cardiac CT in which
better enhancement with higher concentration contrast
medium was found [8, 9]. However, these studies kept
contrast injection rate or injection duration constant,
therefore increasing the iodine flux and/or iodine dose for
the high concentration protocol.
Each of the contrast medium concentrations has its
advantages and disadvantages. Moderate concentration
contrast media are currently used for most types of CT
examinations, which results in a logistic advantage if the
contrast medium (concentration) does not need to be
Table 3 Patient characteristics overall and per weight category
Characteristic
a Overall (n=159) <70 kg (n=22) 70–85 kg (n=77) >85 kg (n=60)
300 mg I/ml 370 mg I/ml 300 mg I/ml 370 mg I/ml 300 mg I/ml 370 mg I/ml 300 mg I/ml 370 mg I/ml
Total no. (men) 84 (61) 75 (60) 15 (7) 7 (5) 40 (31) 37 (27) 29 (23) 31 (31)
Age (years) 58.2 (9.4) 57.0 (9.5) 61.8 (5.6) 61.3 (11.9) 57.5 (7.4) 57.3 (9.6) 57.4 (12.7) 55.7 (8.9)
Heart rate (bpm) 57.6 (8.4) 57.5 (7.6) 59.7 (10.6) 62.9 (4.3) 56.6 (7.6) 58.1 (8.0) 57.9 (8.3) 55.6 (7.2)
Weight (kg) 81.5 (12.6) 83.0 (11.4) 65.4 (3.4) 62.9 (3.7) 77.6 (5.0) 78.2 (4.5) 95.2 (8.6) 93.3 (7.9)
[60–115] [59–118] [60–69] [59–68] [70–85] [70–85] [86–115] [86–118]
BMI (kg/m
2) 26.9 (3.5) 26.9 (3.2) 23.5 (2.2) 23.3 (3.0) 26.1 (2.6) 25.9 (2.2) 29.6 (3.2) 28.9 (2.9)
Numbers are means with standard deviation between parentheses (and for weight the range is between brackets). Only in the first row are
total numbers given with number of men between parentheses
BMI body mass index
aNo significant differences were found between the 300 mg I/ml group and the 370 mg I/ml group regarding these characteristics
1920changed for cardiac CTA. However, the use of lower
concentration contrast media for cardiac CTA requires high
injection rates and thus large needles that can facilitate
these high injection rates. The use of high concentration
contrast medium, on the other hand, allows lower flow
rates and thus smaller needles. Also smaller contrast
medium volumes are needed for administration of an
identical iodine dose. High concentration contrast medium
doses, however, need to be preheated because of its high
viscosity at room temperature. Costs of the two concentra-
tions are probably comparable: high concentration contrast
medium is generally more expensive per volume unit but a
smaller volume can be applied per patient.
Previous studies on arterial contrast enhancement in
cardiac and abdominal CT with varying concentrations of
iodinated contrast medium but equal iodine flux and equal
iodine dose have shown conflicting results. Two studies
with an iodine flux of 1 g/s in cardiac CT did not show an
advantage for a moderate or high concentration contrast
medium [13, 14]. Several studies in either chest or
abdominal CT, one by Suzuki et al. [15] and three recent
studies [16–18], did not find a significant difference in
arterial enhancement either. However, a study by Awai et
al. in abdominal CT, with a very similar set-up as the
aforementioned study by Suzuki et al., did find a benefit for
rapid administration of lower concentration contrast medi-
um [19]. Also, a recent intra-individual comparison in
combined thoraco-abdominal CT by Behrendt et al. found
a better enhancement in the thoracic vessels for contrast
medium with a concentration of 300 mg I/ml compared
with that with a concentration of 370 mg I/ml [20]. It is
unclear why our study and the studies by Awai et al. and by
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Fig. 1 Bars display average
enhancement at each measure-
ment location per contrast me-
dium concentration group for all
subjects (a), and the three
weight categories (b–d); error
bars display one standard
deviation. Significantly higher
enhancement was found in the
lower concentration contrast
medium group (black bars)a t
the measurement locations
in the aorta and left ventricle for
the overall group and the two
higher weight categories but not
in the lowest weight category.
(Asc Ao ascending aorta, Desc
Ao descending aorta, LV left
ventricle, RV right ventricle,
Pulm Art pulmonary artery, cran
cranial, m mid, caud caudal)
1921Behrendt et al. did detect a difference in arterial enhance-
ment in favour of the lower concentration contrast medium
while the other studies did not.
It is difficult to provide an explanation for the difference
in enhancement found in our study especially because we
designed this study to show equal enhancement of the two
concentrations. To better understand the dynamic nature of
the contrast enhancement, one would need to perform a
dynamic imaging procedure of a fixed volume or at a
reference level. However, such a dynamic procedure would
entail a substantial additional radiation dose and extra
contrast medium load for each patient and would have to be
performed before the actual cardiac CT. For this reason, we
can only discuss a number of potential explanations for our
results: the difference in contrast material volumes, the
difference in viscosity, differences in venous pooling or the
dead venous space phenomenon [19].
At identical iodine flux and iodine dose, the injected
contrast material volume is higher, both in total as well as
per unit time, for lower concentration media. At a constant
cardiac output, a higher volume of contrast medium
entering the heart per unit time will lead to less blood
mixing with the contrast material and therefore will cause a
higher contrast concentration in the central blood compart-
ment. This “volume effect” has been suggested by Bae [21]
as an explanation of the effect seen by Awai et al. [19].
Cardiac output, however, does not necessarily have to stay
constant during contrast medium injection: in young
healthy individuals, a sudden volume load may induce an
increase in heart rate and cardiac output while the same
sudden volume load may induce a drop in cardiac output in
older patients with a failing heart. As cardiac output and
enhancement are linked [22], the effect could go either
way: increasing or decreasing enhancement.
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Fig. 1 (continued)
1922The higher viscosity of higher concentration contrast
media could hamper rapid administration and lengthen the
transit time of the contrast medium [7, 23]. The maximum
flow rate in a vein phantom was found to decrease at higher
contrast medium concentration: at 370 mg I/ml the highest
iodine flux was 2.2 g/s or 6 ml/s; at 300 mg I/ml an iodine
flux of 2.4 g/s or 8 ml/s was reached [23]. However, these
maximum injection rates are above the injection rates
used in our study for both the high and moderate
concentration groups and data produced by the contrast
medium injection pump confirm that the required injec-
tion rates were always reached. In addition, we preheated
the 370 mg/ml contrast medium to 37°C to obtain a
viscosity similar to that of 300 mg/ml contrast medium at
room temperature. The fact that we found no significant
difference in time to threshold between the two groups
supports the notion of identical arrival times and
discourages the idea that the more viscous contrast
material travelled more slowly.
Venous pooling occurs when contrast material is
“trapped” in small veins where it travels more slowly and
therefore contributes less to downstream enhancement.
This effect could lead to lower enhancement for more
viscous contrast material or for higher flow rates: more
viscous high concentration contrast medium on its way to
the heart could be trapped in small veins or could stick to
the vessel wall. With an increase in flow rate one could
argue that a higher pressure is built up in the injection vein
during the infusion of contrast medium and contrast
medium may be pushed into smaller veins. The contrast
medium may remain trapped in these small veins until the
pressure in the injection vein drops.
The dead venous space phenomenon refers to the
contrast material that remains in the dead venous space at
the end of a contrast medium injection [19]. This contrast
material no longer travels at the original flow rate but,
at most, at the speed of the venous blood towards the
heart and therefore contributes less to enhancement
than the earlier contrast material that was injected
quickly. This effect increases with the use of high flow
rates that are substantially above the flow rate of
venous blood. In a dual (or triple) phase injection, the
second phase is also subject to such a dead space
phenomenon if the injection rate is decreased between
phases: contrast material in the injection veins travels
no faster than the flow of the second phase of the
injection. Because the volume of the dead space is
identical for the two contrast injection protocols, the
proportion of iodine contained in a given dead space is
larger for higher concentration contrast material due to
the lower volume being injected. In the high concen-
tration group less iodine is therefore travelling with the
high flux of the first phase. The iodine in the venous
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Fig. 2 Enhancement in the ascending aorta versus weight. Note that
the trend lines for both concentrations show that enhancement
decreases with increasing weight in both contrast medium concen-
tration groups despite the use of three weight categories in the
injection protocol
Fig. 3 Examples of axial CT images (left) and curved planar
reformations of the right coronary artery (right) with both 300 mg I/ml
contrast medium (a) and 370 mg I/ml contrast medium (b). Note that
with both concentrations of contrast medium sufficient contrast
enhancement of the heart is reached. The right coronary artery is little
affected by the presence of contrast medium in the right atrium and
ventricle
1923dead space reaches the heart later, which may explain
why right ventricular and pulmonary enhancement did
not show a difference. Recently a split bolus injection
protocol with multiple phases with identical flow rates
but with different contrast concentrations between
phases was described [2]. If the dead space phenomenon
is the explanation for the difference in enhancement
found in our study, its occurrence can be prevented by
using this split bolus injection protocol with identical
injection rates between phases.
This study has several limitations. First, instead of
applying a continuous increase in injection rates with
increasing patient weight, we used three weight categories.
In particular, the highest weight category contained
patients with a large range in weight. A slight decrease in
attenuation was found with increasing weight throughout
each category. The reason why we opted for three
categories was mainly logistic: six preprogrammed injec-
tion protocols in the injector sufficed. Besides, a contin-
uous increase in injection rates with increasing weight
would have resulted in too high injection rates in very
heavy patients. Also, a large variability in enhancement
exists between patients with similar weights, as weight is
not the only patient-related factor that has an effect on
enhancement [24].
Another limitation is the small size of the lowest weight
group. Relatively few patients have a weight below 70 kg
especially in this patient group with cardiovascular disease.
The results in the low weight group below 70 kg were not
consistent with the results in the other two groups.
However, this did not seem to be caused by the small
size of the group, but rather by a true difference between
the weight groups. Lower injection rates, less dead space
and a relatively large iodine dose per kilo patient weight
might be underlying factors.
In conclusion, high concentration contrast material
appears to yield less arterial enhancement compared with
moderate concentration contrast material with a biphasic
injection protocol with reduction of the flow during the
second injection phase and with equal iodine flux and
iodine dose for both contrast material concentrations.
Acknowledgement This study was financially supported by Bayer-
Schering AG, Berlin, Germany. P.R. Seidensticker is an employee of
Bayer-Schering.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are credited.
References
1. Vrachliotis TG, Bis KG, Haidary A,
Kosuri R, Balasubramaniam M,
Gallagher M, Raff G, Ross M, O’Neil
B, O’Neill W (2007) Atypical chest
pain: coronary, aortic, and pulmonary
vasculature enhancement at biphasic
single-injection 64-section CT
angiography. Radiology 243:368–376
2. Kerl JM, Ravenel JG, Nguyen SA,
Suranyi P, Thilo C, Costello P, Bautz
W, Schoepf UJ (2008) Right heart:
split-bolus injection of diluted contrast
medium for visualization at coronary
CT angiography. Radiology 247:356–
364
3. Herman S (2004) Computed
tomography contrast enhancement
principles and the use of high-
concentration contrast media. J Comput
Assist Tomogr 28(Suppl 1):S7–S11
4. Brink JA (2003) Contrast optimization
and scan timing for single and multi-
detector-row computed tomography. J
Comput Assist Tomogr 27(Suppl 1):
S3–S8
5. Husmann L, Alkadhi H, Boehm T,
Leschka S, Schepis T, Koepfli P,
Desbiolles L, Marincek B, Kaufmann P,
Wildermuth S (2006) Influence of
cardiac hemodynamic parameters on
coronary artery opacification with
64-slice computed tomography. Eur
Radiol 16:1111–1116
6. Fleischmann D (2003) Use of high
concentration contrast media: principles
and rationale-vascular district. Eur J
Radiol 45(Suppl 1):S88–S93
7. Blomley MJ, Dawson P (1997) Bolus
dynamics: theoretical and experimental
aspects. Br J Radiol 70:351–359
8. Cademartiri F, de Monye C, Pugliese F,
Mollet NR, Runza G, van der LA, Midiri
M, de Feyter PJ, Lagalla R, Krestin GP
(2006) High iodine concentration con-
trast material for noninvasive multislice
computed tomography coronary angiog-
raphy: iopromide 370 versus iomeprol
400. Invest Radiol 41:349–353
9. Cademartiri F, Mollet NR, van der Lugt
A,McFaddenEP,StijnenT,deFeyterPJ,
Krestin GP (2005) Intravenous contrast
material administration at helical 16-
detector row CT coronary angiography:
effectofiodineconcentrationonvascular
attenuation. Radiology 236:661–665
10. Garcia MJ, Lessick J, Hoffmann MHK,
for the CATSCAN Study Investigators
(2006) Accuracy of 16-row multide-
tector computed tomography for the
assessment of coronary artery stenosis.
JAMA 296:403–411
11. Mollet NR, Cademartiri F, van
Mieghem CAG, Runza G, McFadden
EP, Baks T, Serruys PW, Krestin GP, de
Feyter PJ (2005) High-resolution spiral
computed tomography coronary
angiography in patients referred for
diagnostic conventional coronary
angiography.Circulation112:2318–2323
12. Leber AW, Knez A, von Ziegler F,
Becker A, Nikolaou K, Paul S,
Wintersperger B, Reiser M, Becker CR,
Steinbeck G, Boekstegers P (2005)
Quantification of obstructive and non-
obstructive coronary lesions by 64-slice
computed tomography: a comparative
study with quantitative coronary
angiography and intravascular ultra-
sound. J Am Coll Cardiol 46:147–154
192413. Rist C, Nikolaou K, Kirchin MA, van
GR, Bae KT, von ZF, Knez A,
Wintersperger BJ, Reiser MF, Becker
CR (2006) Contrast bolus optimization
for cardiac 16-slice computed tomo-
graphy: comparison of contrast medium
formulations containing 300 and 400
milligrams of iodine per milliliter.
Invest Radiol 41:460–467
14. Becker CR, Hong C, Knez A, Leber A,
Bruening R, Schoepf UJ, Reiser MF
(2003) Optimal contrast application for
cardiac 4-detector-row computed
tomography. Invest Radiol 38:690–694
15. Suzuki H, Oshima H, Shiraki N, Ikeya
C, Shibamoto Y (2004) Comparison of
two contrast materials with different
iodine concentrations in enhancing the
density of the aorta, portal vein and
liver at multi-detector row CT: a
randomized study. Eur Radiol 14:2099–
2104
16. Behrendt F, Mahnken A, Keil S, Das
M, Hohl C, Bauer D, Seidensticker P,
Jost E, Wildberger J, Guenther R,
Muehlenbruch G (2008) Contrast
enhancement in multidetector-row
computed tomography (MDCT) of the
abdomen: intraindividual comparison
of contrast media containing 300-mg
versus 370-mg iodine per ml. Eur
Radiol 18:1199–1205
17. Behrendt FF, Plumhans C, Keil S,
Mühlenbruch G, Das M, Seidensticker
P, Mutscher C, Günther RW, Mahnken
AH (2009) Contrast enhancement in
chest multidetector computed
tomography: intraindividual
comparison of 300 mg/ml versus
400 mg/ml iodinated contrast medium.
Acad Radiol 16:144–149
18. Muehlenbruch G, Behrendt F,
Eddahabi M, Knackstedt C, Stanzel S,
Das M, Seidensticker P, Günther R,
Wildberger J, Mahnken A (2008)
Which Iodine concentration in chest
CT? A prospective study in
300 patients. Eur Radiol 18:2826–2832
19. Awai K, Inoue M, Yagyu Y, Watanabe
M, Sano T, Nin S, Koike R, Nishimura
Y, Yamashita Y (2004) Moderate
versus high concentration of contrast
material for aortic and hepatic
enhancement and tumor-to-liver
contrast at multi-detector row CT.
Radiology 233:682–688
20. Behrendt FF, Mahnken AH, Stanzel S,
Seidensticker P, Jost E, Gunther RW,
Muhlenbruch G (2008) Intraindividual
comparison of contrast media concen-
trations for combined abdominal and
thoracic MDCT. AJR Am J Roentgenol
191:145–150
21. Bae KT (2005) Comparison of
moderate versus high concentration of
contrast media injected at the same total
iodine dose and fixed injection
duration. Radiology 236:740–741.
doi:10.1148/radiol.2362050096
22. Bae KT, Heiken JP, Brink JA (1998)
Aortic and hepatic contrast medium
enhancement at CT. Part II. Effect of
reduced cardiac output in a porcine
model. Radiology 207:657–662
23. Knollmann F, Schimpf K, Felix R
(2004) Iodine delivery rate of different
concentrations of iodine-containing
contrast agents with rapid injection.
Rofo 176:880–884
24. Bae KT, Seeck BA, Hildebolt CF, Tao
C, Zhu F, Kanematsu M, Woodard PK
(2008) Contrast enhancement in
cardiovascular MDCT: effect of body
weight, height, body surface area, body
mass index, and obesity. AJR Am J
Roentgenol 190:777–784
1925